Humatrope and Back pain - a phase IV clinical study of FDA data

Summary:

Back pain is reported as a side effect among people who take Humatrope (somatropin recombinant), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Synthroid, and have Hypopituitarism.

The phase IV clinical study analyzes which people have Back pain when taking Humatrope. It is created by eHealthMe based on reports of 7,889 people who have side effects when taking Humatrope from the FDA, and is updated regularly.

What is Humatrope?

Humatrope has active ingredients of somatropin recombinant. It is often used in stature short abnormal. eHealthMe is studying from 7,932 Humatrope users. Check the latest studies of Humatrope.

What is Back pain?

Back pain is found to be associated with 3,212 drugs and 4,712 conditions by eHealthMe. Check the latest studies of Back pain.

On Jul, 15, 2026

7,889 people reported to have side effects when taking Humatrope.
Among them, 73 people (0.93%) have Back pain.

Among these 73 people:

How long have people been on Humatrope when they have Back pain? *

What is the gender of people who have Back pain when taking Humatrope? *

female: 40.85 %
male: 59.15 %

What is the age of people who have Back pain when taking Humatrope? *

What are other drugs people take besides Humatrope? *

What are other side effects people have besides Back pain? *

Nausea (feeling of having an urge to vomit): 13 people, 17.81%
Joint Pain: 12 people, 16.44%
Headache (pain in head): 12 people, 16.44%
Pain: 9 people, 12.33%
Stress And Anxiety: 8 people, 10.96%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 10.96%
Drug Ineffective: 8 people, 10.96%
Fall: 7 people, 9.59%
Weakness: 7 people, 9.59%
Abdominal Pain: 7 people, 9.59%

What are the existing conditions these people have? *

Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 8 people, 10.96%
Blood Growth Hormone Decreased: 4 people, 5.48%
Hypothalamo-Pituitary Disorders (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 2 people, 2.74%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 2.74%
Sleep Disorder: 1 person, 1.37%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 1.37%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 1.37%
Bedwetting: 1 person, 1.37%
Body Height Below Normal: 1 person, 1.37%
Brain Neoplasm (tumour of brain): 1 person, 1.37%

* Approximation only. Some reports may have incomplete information.

Do you take Humatrope and have Back pain?

- Check whether Back pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humatrope:

Humatrope (7,932 reports)

Back pain treatments and more:

Back pain (379,875 reports)

Browse all side effects of Humatrope:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Back pain:

Back pain (3,212 drugs)

Browse all the conditions that are associated with Back pain:

Back pain (4,712 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on somatropin recombinant (the active ingredients of Humatrope) and Humatrope (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.